CD274 and neoplasm: For ID8-VEGF, tumor regression was observed in 25% of test animals after PD-1 blockade, 25% with CTLA-4 blockade, and 37.5% with PD-L1 blockade, as compared to 50% with combined CTLA-4 plus PD-1 or PD-L1 blockade.